These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 7167398)

  • 21. Opiate receptors and cardiovascular control in conscious SHR and WKY rats.
    Feuerstein G; Zerbe RL; Faden AI
    Hypertension; 1983; 5(5):663-71. PubMed ID: 6311737
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential cardiovascular and respiratory responses to central administration of selective opioid agonists in conscious rabbits: correlation with receptor distribution.
    May CN; Dashwood MR; Whitehead CJ; Mathias CJ
    Br J Pharmacol; 1989 Nov; 98(3):903-13. PubMed ID: 2556206
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dermenkephalin (Tyr-D-Met-Phe-His-Leu-Met-Asp-NH2): a potent and fully specific agonist for the delta opioid receptor.
    Amiche M; Sagan S; Mor A; Delfour A; Nicolas P
    Mol Pharmacol; 1989 Jun; 35(6):774-9. PubMed ID: 2543911
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bis-penicillamine enkephalins possess highly improved specificity toward delta opioid receptors.
    Mosberg HI; Hurst R; Hruby VJ; Gee K; Yamamura HI; Galligan JJ; Burks TF
    Proc Natl Acad Sci U S A; 1983 Oct; 80(19):5871-4. PubMed ID: 6310598
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Central effects of mu, delta, and kappa receptor agonists in hemorrhagic shock.
    Feuerstein G; Powell E; Faden AI
    Peptides; 1985; 6 Suppl 1():11-3. PubMed ID: 2995939
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Central cardiovascular effects of morphinomimetic peptides in dogs.
    Laubie M; Schmitt H; Vincent M; Remond G
    Eur J Pharmacol; 1977 Nov; 46(1):67-71. PubMed ID: 923652
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of opioid receptors mediating stimulation of adenylate cyclase activity in rat olfactory bulb.
    Olianas MC; Onali P
    Mol Pharmacol; 1992 Jul; 42(1):109-15. PubMed ID: 1321951
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of kappa opioid receptors in modulating cholinergic twitches in the circular muscle of guinea-pig colon.
    Giuliani S; Lecci A; Tramontana M; Maggi CA
    Br J Pharmacol; 1996 Nov; 119(5):985-9. PubMed ID: 8922749
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cardiovascular interactions between methionine-enkephalin and substance P in the conscious dog.
    Sander GE; Giles TD; Rice JC
    Peptides; 1985; 6(1):133-7. PubMed ID: 2581232
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of mu-opioid receptor agonists on circulatory responses to simulated haemorrhage in conscious rabbits.
    Evans RG; Ludbrook J
    Br J Pharmacol; 1990 Jul; 100(3):421-6. PubMed ID: 2167731
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Different profile of electrocortical power spectrum changes after micro-infusion into the locus coeruleus of selective agonists at various opioid receptor subtypes in rats.
    Bagetta G; De Sarro GB; Sakurada S; Rispoli V; Nisticò G
    Br J Pharmacol; 1990 Nov; 101(3):655-61. PubMed ID: 1963804
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cardiovascular and respiratory effects of mu-, delta- and kappa-opiate agonists microinjected into the anterior hypothalamic brain area of awake rats.
    Pfeiffer A; Feuerstein G; Kopin IJ; Faden AI
    J Pharmacol Exp Ther; 1983 Jun; 225(3):735-41. PubMed ID: 6306217
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evidence for mu opioid receptor mediation of enkephalin-induced electroencephalographic seizures.
    Tortella FC; Robles L; Mosberg HI
    J Pharmacol Exp Ther; 1987 Feb; 240(2):571-7. PubMed ID: 3027318
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cardiovascular and respiratory effects of dermorphin in rats.
    Portolano F; Filippelli A; Marrazzo R; Susanna V; Russo S; Stella L; Losasso C; Budetta SN; Molinario L; Angrisani M
    Res Commun Chem Pathol Pharmacol; 1991 Feb; 71(2):131-52. PubMed ID: 1675473
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Receptors for opioid peptides in the guinea-pig ileum.
    Takemori AE; Portoghese PS
    J Pharmacol Exp Ther; 1985 Nov; 235(2):389-92. PubMed ID: 2997432
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hypothalamic opioid mu-receptors regulate discrete hemodynamic functions in the conscious rat.
    Sirén AL; Feuerstein G
    Neuropharmacology; 1991 Feb; 30(2):143-52. PubMed ID: 1851544
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regional haemodynamic effects of mu-, delta-, and kappa-opioid agonists microinjected into the hypothalamic paraventricular nuclei of conscious, unrestrained rats.
    Bachelard H; Pître M
    Br J Pharmacol; 1995 Jun; 115(4):613-21. PubMed ID: 7582480
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cyclic dermorphin-like tetrapeptides with delta-opioid receptor selectivity. 3. Effect of residue 3 modification on in vitro opioid activity.
    Mosberg HI; Heyl DL; Haaseth RC; Omnaas JR; Medzihradsky F; Smith CB
    Mol Pharmacol; 1990 Dec; 38(6):924-8. PubMed ID: 2174509
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influence of peptidase inhibitors on the apparent agonist potency of delta selective opioid peptides in vitro.
    Kramer TH; Toth G; Haaseth RC; Matsunaga TO; Davis P; Hruby VJ; Burks TF
    Life Sci; 1991; 48(9):881-6. PubMed ID: 1847736
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Central opioid receptors and baroreflex control of sympathetic and cardiovascular function.
    Gordon FJ
    J Pharmacol Exp Ther; 1986 May; 237(2):428-36. PubMed ID: 3009782
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.